Impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromes
OBJECTIVE: To determine whether previous insulin treatment independently influences subsequent outcomes in diabetic patients with ACS (acute coronary syndromes). SUBJECTS AND METHODS: 375 diabetic patients with ACS, divided in 2 groups: Group A (n = 69) - previous insulin and Group B (n = 306) - without previous insulin. Predictors of 1-year mortality and major adverse cardiac events (MACE) were analyzed by Cox regression analysis. RESULTS: Group A had more previous stroke (17.4% vs. 9.2%, p = 0.047) and peripheral artery disease (13.0% vs. 3.6%, p = 0.005). They had significantly higher admission glycemia and lower LDL cholesterol. There were no significant differences in the type of ACS, in 1-year mortality (18.2% vs. 10.4%, p = 0.103) or MACE (32.1% vs. 23.0%, p = 0.146) between groups. In multivariate analysis, insulin treatment was neither an independent predictor of 1-year mortality nor of MACE. CONCLUSION: Despite the more advanced atherosclerotic disease, diabetics under insulin had similar outcomes to those without insulin. Insulin may protect diabetics from the expected poor adverse outcome of an advanced atherosclerotic disease.
Main Authors: | , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Endocrinologia e Metabologia
2010
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302010000700005 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0004-27302010000700005 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0004-273020100007000052010-11-03Impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromesAntónio,NatáliaSoares,FranciscoLourenço,CarolinaSaraiva,FátimaGonçalves,FranciscoMonteiro,PedroGonçalves,LinoFreitas,MárioProvidência,Luís A. Insulin diabetes acute coronary syndromes outcomes OBJECTIVE: To determine whether previous insulin treatment independently influences subsequent outcomes in diabetic patients with ACS (acute coronary syndromes). SUBJECTS AND METHODS: 375 diabetic patients with ACS, divided in 2 groups: Group A (n = 69) - previous insulin and Group B (n = 306) - without previous insulin. Predictors of 1-year mortality and major adverse cardiac events (MACE) were analyzed by Cox regression analysis. RESULTS: Group A had more previous stroke (17.4% vs. 9.2%, p = 0.047) and peripheral artery disease (13.0% vs. 3.6%, p = 0.005). They had significantly higher admission glycemia and lower LDL cholesterol. There were no significant differences in the type of ACS, in 1-year mortality (18.2% vs. 10.4%, p = 0.103) or MACE (32.1% vs. 23.0%, p = 0.146) between groups. In multivariate analysis, insulin treatment was neither an independent predictor of 1-year mortality nor of MACE. CONCLUSION: Despite the more advanced atherosclerotic disease, diabetics under insulin had similar outcomes to those without insulin. Insulin may protect diabetics from the expected poor adverse outcome of an advanced atherosclerotic disease.info:eu-repo/semantics/openAccessSociedade Brasileira de Endocrinologia e MetabologiaArquivos Brasileiros de Endocrinologia & Metabologia v.54 n.7 20102010-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302010000700005en10.1590/S0004-27302010000700005 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
António,Natália Soares,Francisco Lourenço,Carolina Saraiva,Fátima Gonçalves,Francisco Monteiro,Pedro Gonçalves,Lino Freitas,Mário Providência,Luís A. |
spellingShingle |
António,Natália Soares,Francisco Lourenço,Carolina Saraiva,Fátima Gonçalves,Francisco Monteiro,Pedro Gonçalves,Lino Freitas,Mário Providência,Luís A. Impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromes |
author_facet |
António,Natália Soares,Francisco Lourenço,Carolina Saraiva,Fátima Gonçalves,Francisco Monteiro,Pedro Gonçalves,Lino Freitas,Mário Providência,Luís A. |
author_sort |
António,Natália |
title |
Impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromes |
title_short |
Impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromes |
title_full |
Impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromes |
title_fullStr |
Impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromes |
title_full_unstemmed |
Impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromes |
title_sort |
impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromes |
description |
OBJECTIVE: To determine whether previous insulin treatment independently influences subsequent outcomes in diabetic patients with ACS (acute coronary syndromes). SUBJECTS AND METHODS: 375 diabetic patients with ACS, divided in 2 groups: Group A (n = 69) - previous insulin and Group B (n = 306) - without previous insulin. Predictors of 1-year mortality and major adverse cardiac events (MACE) were analyzed by Cox regression analysis. RESULTS: Group A had more previous stroke (17.4% vs. 9.2%, p = 0.047) and peripheral artery disease (13.0% vs. 3.6%, p = 0.005). They had significantly higher admission glycemia and lower LDL cholesterol. There were no significant differences in the type of ACS, in 1-year mortality (18.2% vs. 10.4%, p = 0.103) or MACE (32.1% vs. 23.0%, p = 0.146) between groups. In multivariate analysis, insulin treatment was neither an independent predictor of 1-year mortality nor of MACE. CONCLUSION: Despite the more advanced atherosclerotic disease, diabetics under insulin had similar outcomes to those without insulin. Insulin may protect diabetics from the expected poor adverse outcome of an advanced atherosclerotic disease. |
publisher |
Sociedade Brasileira de Endocrinologia e Metabologia |
publishDate |
2010 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302010000700005 |
work_keys_str_mv |
AT antonionatalia impactofpreviousinsulintherapyontheprognosisofdiabeticpatientswithacutecoronarysyndromes AT soaresfrancisco impactofpreviousinsulintherapyontheprognosisofdiabeticpatientswithacutecoronarysyndromes AT lourencocarolina impactofpreviousinsulintherapyontheprognosisofdiabeticpatientswithacutecoronarysyndromes AT saraivafatima impactofpreviousinsulintherapyontheprognosisofdiabeticpatientswithacutecoronarysyndromes AT goncalvesfrancisco impactofpreviousinsulintherapyontheprognosisofdiabeticpatientswithacutecoronarysyndromes AT monteiropedro impactofpreviousinsulintherapyontheprognosisofdiabeticpatientswithacutecoronarysyndromes AT goncalveslino impactofpreviousinsulintherapyontheprognosisofdiabeticpatientswithacutecoronarysyndromes AT freitasmario impactofpreviousinsulintherapyontheprognosisofdiabeticpatientswithacutecoronarysyndromes AT providencialuisa impactofpreviousinsulintherapyontheprognosisofdiabeticpatientswithacutecoronarysyndromes |
_version_ |
1756372708431495168 |